For instance, combining GSK3β inhibitors with agents that activate autophagy or inhibit the mTOR pathway may provide synergistic effects, particularly in neurodegenerative diseases where autophagic dysfunction is prevalent (Rodríguez-Urgellés et al., 2022). Here, MTOR is linked to neurodegenerative disease.